Minocycline is a widely used glial activation inhibitor that could suppress pain-related behaviors in a number of different pain animal models, yet, its analgesic mechanisms are not fully understood. Hyperpolarization-activated cation channel-induced Ih current plays an important role in neuronal excitability and pathological pain.
Introduction
Hyperpolarization-activated cation current (Ih) is conducted by hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and has been described in multiple neuronal types, such as thalamic neurons, hippocampal CA1 pyramidal neurons, primary afferent neurons, and spinal dorsal horn neurons (Doan et al., 2004; Gao et al., 2012; Ingram and Williams, 1996; McCormick and Pape, 1990; Nolan et al., 2004; Rivera-Arconada et al., 2013) . It is a mixed inward cationic current carried by Na þ and K þ . Therefore, Ih depolarizes the plasma membrane, brings the membrane potential toward the firing threshold. Diverse functions have been attributed to Ih, including the determination of resting membrane potential (RMP), action potential (AP) firing rate, dendritic integration, and synaptic transmission (Biel et al., 2009; He et al., 2014) . The HCN channel family has four distinct members (HCN1-4) (Biel et al., 2009) . In superficial spinal dorsal horn, complete Freund's adjuvant-induced inflammation increased HCN2 expression (Weng et al., 2012) . Genetic deletion of HCN2 in nociceptors eliminated Ih and abolished AP firing, which results in non-response to pathological pain stimulation (Emery et al., 2011) . In an HCN1 À/À mouse model for neuropathic pain, cold allodynia was attenuated compared to wild-type mice (Momin et al., 2008) . In addition, the selective Ih channel blocker ZD7288 reduced licking/biting behavior in formalin test, probably due to the reduction of A/Cfiber-mediated evoked excitatory postsynaptic currents (eEPSCs) and the frequency of miniature EPSCs in substantia gelatinosa (SG) neurons (Takasu et al., 2010) . SG (lamina II of Rexed in spinal dorsal horn) is a narrow cellular band near the dorsal limit of the gray matter. SG is thought to be consisted of both excitatory and inhibitory neurons interconnected in a complicated, but not completely characterized circuit. However, it has been demonstrated that a vast majority of neurons are excitatory interneurons in SG (Santos et al., 2007) . SG integrates nociceptive information from periphery before transmitting to brain and thus is a critical site in pain modulation (Wall, 1980) . These studies indicate that Ih is a critical contributor and an attractive target for the treatment of inflammatory and neuropathic pain. Over the past decade or so, an increasing number of studies have been reported to develop therapy for this type of pain. For instance, although minocycline is a second-generation of semi-synthetic tetracycline that has been used as a broad-spectrum antibiotic for over 30 years, its analgesic property was initially described in 2003 (Raghavendra et al., 2003) . In a rat model of L5 spinal nerve transection, intraperitoneal administration of minocycline potently attenuated mechanical allodynia and hyperalgesia. More recently, growing interest in minocycline has led to evaluations of its efficacy in various pain experimental models, such as formalin-evoked inflammatory pain (Cho et al., 2006; Hua et al., 2005) , spinal nerve ligation (SNL) or chronic constriction injury (CCI) induced neuropathic pain (Katsura et al., 2006; Owolabi and Saab, 2006; Zanjani et al., 2006; Zhuang et al., 2005) , burn injury pain (Chang and Waxman, 2010) , diabetic neuropathic pain (Liao et al., 2011; Pabreja et al., 2011; Syngle et al., 2014) , visceral pain (Cho et al., 2012; Liu et al., 2012) , and cancer induced pain (Mao-Ying et al., 2012) . In addition, minocycline has been shown to enhance the analgesic effect when co-administered with morphine or tramadol (Makuch et al., 2013; Mei et al., 2013; Mika et al., 2009; Zychowska et al., 2013) . The mechanism underlying minocycline-induced analgesia could be mediated by suppressing microglial activation, which is independent of its antimicrobial action. Besides inhibition of glial activation, minocycline may also directly affect neuronal activity, indicating a non-glial mechanism of action. Also, several studies have revealed that minocycline exerts anti-nociceptive effect by reducing neural excitability. For instance, minocycline inhibited Na þ channel currents in DRG (Kim et al., 2011) . Bath application of minocycline reversibly inhibited nearly 30% of eEPSCs amplitude in SG neurons, which was compatible to ZD7288's effect on eEPSCs in SG (Cho et al., 2006; Takasu et al., 2010) . Regardless of the progress made in understanding the analgesic action of minocycline as mentioned above, the mechanism underlying this neural analgesic effect still remains elusive. Given the crucial role of Ih in pain and widespread expression of HCN channels in spinal dorsal horn (Antal et al., 2004; Hughes et al., 2013; Papp et al., 2006; Tu et al., 2004; Weng et al., 2012) , we hypothesized that minocycline might exert its anti-nociceptive effect by suppressing excitability of SG neuron through action on HCN channels. Therefore, in this study, we tested this hypothesis by examining the action of minocycline on Ih using whole-cell patchclamp recording in SG neurons of rat spinal cord. As a result, we found that minocycline decreases Ih amplitude, alters activationedeactivation properties of Ih, and further decreases frequency of AP. This finding might at least interpret how minocycline can exert its neuronal analgesic action by suppressing excitability of SG.
Materials and methods
Male Sprague Dawley rats (3e5 weeks old) were used in this study. All experimental protocols were approved by the Institutional Animal Care and Use Committee of Nanchang University. All efforts were made to minimize animal suffering and reduce the number of animals used.
Spinal cord slice preparation
Spinal cord slices were prepared as described previously (Lu et al., 2013; Yasaka et al., 2010; Zheng et al., 2010) . In brief, rats were anesthetized with urethane (1.5 g/ kg, i.p.), and then perfused transcardially for 2 min with ice-cold oxygenated (95% O 2 and 5% CO 2 ) sucrose-substituted artificial cerebrospinal fluid (sucrose-ACSF: 240 mM sucrose; 2.5 mM KCl; 0.5 mM CaCl 2 ; 3.5 mM MgCl 2 ; 1.25 mM NaH 2 PO 4 ; 25 mM NaHCO 3 ; 0.4 mM ascorbate acid; and 2 mM pyruvate). The lumbosacral spinal cord was quickly removed and placed in ice-cold oxygenated sucrose-ACSF. After extraction and still under anesthesia, animals were sacrificed by decapitation. Parasagittal slices (300-mm thick) were prepared using a vibrating microslicer (VT1000S; Leica). The slices were incubated at 32 C for at least 30 min in regular ACSF (117 mM NaCl; 3.6 mM KCl; 2.5 mM CaCl 2 ; 1.2 mM MgCl 2 ; 1.2 mM NaH 2 PO 4 ; 25 mM NaHCO 3 ; 11 mM D-glucose; 0.4 mM ascorbic acid; and 2 mM pyruvate) equilibrated with 95% O 2 and 5% CO 2 .
Electrophysiological recording
The electrophysiological recording procedures and labeling of neurons were conducted basically as described previously (Rivera-Arconada et al., 2013; Yasaka et al., 2010) . Specifically, an individual slice was transferred to a recording chamber and placed on the stage of an upright microscope (BX51WI; Olympus). Tight seal, whole-cell patch-clamp recordings were performed at room temperature (22e24 C) and perfused at a rate of 2e4 ml/min with ACSF. SG neurons in lumbar segments L4-L5 were identified by their locations and visualized under guidance of an infrared and differential interference contrast (IR-DIC) camera. Recording pipettes were fabricated from borosilicate glass capillaries (1.5 mm OD, 1.12 mm ID; World Precision Instruments) on a micropipette puller (P-97; Sutter Instrument) and had a resistance of 4e6 MU when filled with a solution containing the following: 130 mM K-gluconate; 5 mM KCl; 4 mM Mg-ATP; 10 mM phosphocreatinine; 0.3 mM Li-GTP; 10 mM Hepes (pH 7.3 adjusted with KOH, 300 mOsm). No correction for the liquid junction potential was made. Signals were amplified using an EPC-10 amplifier with Patchmaster software (HEKA) and stored for off-line analysis. In this study, the series resistances were usually 30e50 MU. Neurons that showed a RMP more positive than À50 mV and their series resistance changed by more than 20% were excluded from analysis.
Experimental protocol
Somatic Ih current was activated as described previously (Gao et al., 2012; Weng et al., 2012) . In current-clamp mode, a series of negative current injections (À30 to À300 pA with a step of À30 pA, 1 s duration) was applied to evoke a set of voltage sags [in our study, some of the neurons can't tolerate excessive hyperpolarizing current, so we used a smaller current intensity than used in DRG (Gao et al., 2012) ]. In voltage-clamp mode, Ih was evoked by a series of hyperpolarizing step voltage pulses from a holding potential of À50 mV to À130 mV for 1 s in 10-mV increments. Ih amplitude was measured as the difference between the initial (instantaneous) inward current (Iini) and the steady state current (Iss) at À130 mV unless mentioned otherwise. The Iini was measured 12e15 ms after the start of the voltage command to avoid contamination by capacitative artifacts.
For voltage dependent activation studies, neuron was held at À50 mV, and Ih currents were allowed to be partially activated by hyperpolarizing test commands within the range from À60 to À130 mV in 10-mV increments (duration: 1 s). The neuron was then subjected to a voltage jump to À130 mV to obtain full activation of Ih currents. Instantaneous tail currents were normalized to the maximum value obtained with the À130 mV prepulse and plotted against the corresponding prepulse voltages to yield activation curves. The curve was fitted with a Boltzmann sigmoid equation:
, in which Imax represents the maximal current amplitude, V 0.5 is the voltage, at which the current is one half of its maximal level, V is the membrane voltage, and k is the constant slope factor. Ih density was calculated by dividing Ih amplitude by cell capacitance.
The currentevoltage (IeV) relationship of Ih was obtained from tail currents measured with the following voltage protocol. The membrane potential was stepped to À130 mV for 1 s from a holding potential of À50 mV to fully activate Ih followed by a depolarization to test potentials of À120 to À50 mV in 10-mV increments. The time point for measurement of the peak tail current is usually just after the capacitive transient at each test voltage. The recorded tail current amplitudes were plotted against each test potential to construct the IeV lines. Reversal potential (Vrev) is the intersection of the IeV line with the X-axis.
APs were evoked with a series of depolarizing current (25e175 pA in 25 pA steps) injections of 1-s duration in current-clamp mode. AP frequency was determined as the spike number in 1 s.
Application of drugs
All drugs were bath applied by gravity perfusion via a three-way stopcock without any change in the perfusion rate. The time necessary for the solution to flow from the stopcock to the surface of the spinal cord slice was approximately 10 s. The drugs used here include minocycline, 1 mM CsCl (a nonspecific Ih blocker), 10 mM ZD7288, 0.1 mM NiCl 2 (a voltage-gated Ca 2þ channel blocker), 1 mM 4-AP (a lowvoltage activating potassium channel blocker), 10 mM TEA (a high-voltage activating potassium channel blocker), 1 mM BaCl 2 (an inward-rectifier K þ channel blocker), 0.5 mM TTX (a sodium channel blocker), 10 mM CNQX (an AMPA/kainite receptor antagonist), 50 mM D-APV (an NMDA receptor antagonist), 10 mM bicuculine methiodide (a GABA A receptor antagonist), 1 mM strychnine (a glycine receptor antagonist), and 50 mM forskolin (a potent nonspecific adenylyl cyclase activator).
CsCl, BaCl 2 , NiCl 2 , TEA, and 4-AP were freshly dissolved at the final concentration directly in ACSF before use. Stock of CNQX and froskolin were first dissolved in dimethyl sulphoxide (DMSO), and the other drugs were prepared in distilled water at 1000 times the concentrations to be used and stored at À20 C. These drugs were then diluted to the final concentration in ASCF solution immediately before use. The concentration of DMSO in ASCF solution containing the drugs was <0.1%. TTX, ZD7288, CNQX, D-APV, and forskolin were purchased from Tocris Bioscience (Bristol, UK). All the other drugs were obtained from SigmaeAldrich (St. Louis, MO). The determination of doses for each drug was based on those found to be effective in previous studies (Cho et al., 2006; Rivera-Arconada et al., 2013; Yao et al., 2003) .
Statistical analysis
All statistical analyses and curve fittings were performed using GraphPad Prism 5.0 (GraphPad Software, USA). Data are expressed as mean ± SEM unless otherwise mentioned, and n refers to the number of neurons studied. Statistical significance of data from different drug conditions was assessed with Student's t-test, one-or twoway ANOVA as appropriate. Statistical significance is indicated as follows: *P < 0.05; **P < 0.01; and ***P < 0.001.
Results

Recording Ih currents in SG neurons
Whole-cell recordings were obtained from a total of 169 SG neurons with Ih currents. These neurons were identified using IR-DIC video microscopy based on their location, which is lateral to the dorsal column and distinguished as a relatively translucent band (Fig. 1Aa) . A typical example of an SG neuron is shown along with their morphology (Fig. 1Ab, c) , indicating that the cell body is clearly located in lamina II with numerous dendritic trees. As described previously (Liu et al., 2013) , all SG neurons examined had RMP more negative than À50 mV in this study when measured in the current-clamp mode. When tested with a series of hyperpolarizing current (Fig. 1B top) or voltage pulses (Fig. 1C top) , some of these neurons exhibited a depolarizing "sag" (Fig. 1B bottom) or inward current (Fig. 1C bottom) , due to activation of HCN channel. Ih was comprised of Iini and Iss (Fig. 1C bottom) and displayed reproducible time and voltage-dependent activation patterns similar to those previously stated (Gao et al., 2012; Liu et al., 2003) . Consistent with the previously reported Ih in SG, Ih was observed in nearly 50% (169/340) of recorded cells, which were chosen for further testing (Grudt and Perl, 2002; Melnick, 2008; Tadros et al., 2012; Yasaka et al., 2010) .
To ensure that the current recorded in this study is Ih, we examined the effect of CsCl and ZD7288 on Ih, both of which have been shown to block Ih current effectively. Similar to a previous study (Doan et al., 2004) , we found that Ih currents are blocked by CsCl and ZD7288 (Fig. 1D, E) . To further determine whether Ih currents recorded in SG neurons are contaminated by other currents, such as voltage-gated potassium and calcium currents, we bath applied BaCl 2 , 4-AP, TEA, or NiCl 2 to the slices, respectively (Dibattista et al., 2008; Du et al., 2013; Kwak, 2012; RiveraArconada et al., 2013) . We found that Ih currents are not significantly changed by BaCl 2 , NiCl 2 , 4-AP, and TEA (Fig. 1DeG) . These results confirmed that the current recorded in SG neurons is HCN channel-mediated Ih current, with little or no contamination with other currents.
The four subtypes of HCN channels exhibit distinct cAMPsensitivity. HCN2 and HCN4 can be modulated positively, however, HCN1 and HCN3 are insensitive to cAMP (He et al., 2014) . To assess whether HCN channels in SG neurons contain the cAMPsensitive subunits, 50 mM forskolin was bath applied for 10 min to spinal slices. In only 4 of 21 neurons examined, forskolin caused an increase in Ih amplitude (156 ± 25%, P < 0.05; Fig. 1F ). Other 17 neurons were not affected by forskolin. Thus, these results indicate that most of the Ih currents recorded in this study are induced by cAMP-insensitive HCN channels, probably HCN1 or HCN3. The distinct composition of HCN channel in SG neurons requires further study. The effects of different channel blockers and forskolin on Ih current amplitude are summarized in Fig. 1G. 
Minocycline decreases the amplitude of Ih in SG neurons
Although recent studies showed the modulation of neuronal excitability by minocycline, little is known about if this medicine might modulate Ih. In the present study, minocycline was given for 3 min and the maximum effects were measured 3e5 min after bath application of minocycline. Control Ih amplitude was measured 1 min before the application of minocycline. There was some variability in Ih amplitude among neurons, ranging from À24 to À590 pA (À171 ± 12 pA; n ¼ 169). After superfusion of 100 mM minocycline, the amplitude of Ih significantly decreased to 62 ± 5% (n ¼ 15; P < 0.01) of the control (À145 ± 27 pA; Fig. 2A, B) . In 15 cells, a recovery of current amplitude to 84 ± 7% was observed after washing out minocycline (P > 0.05; Fig. 2A, B) . As shown in the time course experiment (Fig. 2C) , Ih amplitude decreased right after minocycline application and reached a maximum level within approximately 3e5 min afterward. The decrease usually subsided within 20e30 min after washout of minocycline. These results indicate that minocycline rapidly inhibits Ih in SG neurons, which is reversible.
Two previous studies revealed the presence of HCN channels in certain axons and presynaptic terminals of nociceptive primary afferents by immunohistochemical staining (Antal et al., 2004; Papp et al., 2010) . To examine whether presynaptic HCN channels and synaptic transmission are involved in minocycline-induced reduction of Ih, we co-applied a mixed blocker solution containing TTX, CNQX, D-APV, bicuculine methiodide, and strychnine. As shown in Fig. 2E and F, minocycline caused a significant decrease in magnitude of Ih when slices were pre-superfused with the mixed blockers (60 ± 7% of control: À181 ± 56 pA; n ¼ 8; P < 0.01), which was comparable to the Ih inhibition by bath application of minocycline (Fig. 2G) . Therefore the inhibitory effect of minocycline on Ih is unlikely to be associated with axonal and presynaptic HCN channels as summarized in Fig. 2G .
To further elucidate the site of minocycline's action, we tested the efficacy of intracellularly versus extracellularly applied minocycline. Inclusion of 100 mM minocycline in the pipette solution did not affect Ih amplitude (94 ± 4% of control: À206 ± 69 pA; n ¼ 4; P > 0.05) after establishing whole-cell configuration within 10 min (Fig. 3A, B) . However, when we continued to apply extracellular minocycline (100 mM) to the same neuron, Ih amplitude was decreased rapidly (67 ± 9%, n ¼ 4; P < 0.05) (Fig 3C) . These results as summarized in Fig. 3D indicate an extracellular location of the minocycline binding site. 
Minocycline-induced reduction of Ih in SG neurons is concentration-dependent
To determine IC 50 for the inhibitory effect of minocycline on Ih, we performed a dose-dependent experiment by using a standard voltage protocol (see Fig. 1D ) in the absence or presence of increasing amounts of minocycline. Indeed, as shown in Fig. 4AeC , this medicine inhibited Ih in a dose-dependent fashion. Hill plot analysis of the data revealed that the IC 50 value of this inhibition is 41 mM with a Hill coefficient of 2.2.
Negative shift of Ih activation curve by minocycline
To examine whether minocycline modulates HCN channel activation in SG neurons, we employed the protocol for activation curve plotting (Fig. 5A) . The tail currents were shown in detail in Fig. 5B . The activation curves were fitted by using the Boltzmann equation (see the Methods) and generated before and after superfusion of 100 mM minocycline (each point represents the mean ± SEM of 10 cells; Fig. 5D ). V 0.5 were À86.9 ± 1.4 mV in control conditions and À95.5 ± 1.7 mV in the presence of minocycline, which revealed a negative shift of À8.6 mV (n ¼ 10; P < 0.05, Fig. 5D ). However, the slope factors for control (12.0 ± 1.3 mV) and minocycline (14.3 ± 1 mV) were not significantly different (P > 0.05).
When normalized to cell capacitance, superfusion of minocycline had a significant decrease in Ih current density by 40e45% compared with control neurons over the voltage range from À100 to À130 mV (n ¼ 10; Fig 5E) . Although at À70 mV, the current density values obtained in the absence and presence of minocycline were similar (0.4 ± 0.2 and 0.2 ± 0.1 pA/pF, respectively), at À130 mV, these values were significantly different (7.8 ± 1.6 and 4.7 ± 1.0 pA/pF, respectively; P < 0.05) with a 40% decrease in the latter group (Fig. 5E) .
Effects of minocycline on reversal potential of Ih current
To further examine the effects of minocycline on the Vrev of Ih in SG neurons, we used the voltage protocol described in the preceding text (Fig. 6A) . Tail currents were measured at the start of the test potentials and time point for measuring the peak tail current is shown in Fig. 6B . Minocycline reduced tail current amplitude compared to the control group (Fig. 6C) . IeV curve was generated in 8 Ih-expressing neurons (Fig. 6D) . The intercept of the resulting curve with the X-axis and the slope represented Vrev and conductance, respectively. The Vrev values of À42.0 ± 0.5 mV obtained after the application of 100 mM minocycline were not was À86.9 mV in control and À95.5 mV in minocycline, a negative shift of À8.6 mV (n ¼ 10). E: Ih current density (current amplitude/cell capacitance) versus membrane potential. Error bars indicate SEM.
significantly different from the control group, À40.7 ± 0.5 mV (n ¼ 8; P > 0.05), suggesting that minocycline did not change the ion selectivity of HCN channels. This Vrev is consistent with a mixed cation channel permeable for sodium and potassium and is in the range of Vrev described for HCN channels (Van Hook and Berson, 2010) .
Minocycline decreases AP firing rates in SG neurons
Given the critical role of Ih in determining intrinsic excitability, we further determined whether minocycline would affect the basic ionic mechanisms of spike generation in SG neurons. An example of the responses of one SG neuron to depolarizing current injections in the absence and presence of minocycline is shown in Fig. 7A . This result revealed the reduction of firing frequency. As illustrated in Fig. 7B , minocycline slowed down the slope of the depolarization ramp leading to AP threshold and prolonged interspike intervals resulting in the reduction of spike frequency. Bath application of minocycline decreased AP firing rate from 32 ± 5 to 16 ± 4 Hz (n ¼ 8; P < 0.05) by a 175 pA current injection (Fig. 7A, D) . However, superimposition of AP spikes recorded before and after application of minocycline revealed minimal effects on the amplitude, duration, and shape of the APs (Fig 7C) . The decreases in spike numbers of 8 neurons as summarized in Fig 7D strongly indicate that minocycline markedly alters the intrinsic properties of SG neurons.
Discussion
The results as presented here demonstrate that minocycline acutely and significantly decreases the Ih amplitude of SG neurons, which is irrelevant to its antibiotic and inhibitory effect on microglia activation. This reduction was mediated by postsynaptic HCN channels and independent of the cAMP-induced intracellular signaling pathway. We also found that minocycline shifts Ih current activation curve to a more negative level, but do not alter Vrev. In addition, minocycline strongly decreased firing rates of APs by slowing down the inter-spike depolarizing slope.
It is generally accepted that both central and peripheral administration of minocycline exerts anti-inflammatory and neuroprotective effects. Moreover, a number of studies indicate that minocycline could be used as an antinociceptive agent in pain management, although the underlying mechanisms remain obscure. The effect of minocycline might be related to multiple mechanisms, including decreased microglial activation (Martinez et al., 2013; Pevida et al., 2013) and subsequent pro-inflammatory cytokine generation (Mao-Ying et al., 2012; Mei et al., 2013) , increased antinociceptive factors (IL-1a, IL-2, IL-10, sTNFRII) , decreased glutamine release (Huang et al., 2014) , and inhibited NMDAR1 expression (Pu et al., 2013) . Based on the time course of minocycline's effect in our study, the acute reduction of minocycline on Ih (within several minutes) might not be due to its inhibitory effect on microglial activation (usually within several days to weeks) (Tanga, 2005) . Moreover, special attention has been paid to minocycline's effect on the modulation of neural excitability. For instance, minocycline blocked voltagedependent Na þ -and Ca 2þ -channels in hippocampal neurons (Gonzalez et al., 2007) , inhibited Na þ currents in DRG neurons (Kim et al., 2011) , and decreased eEPSCs in SG neurons (Cho et al., 2006) . We further showed here for the first time that minocycline directly inhibits somatic HCN channels and hence decreases the excitability of SG neuron in the spinal dorsal horn. IC 50 values for the reduction of minocycline on Ih was 41 mM, which is comparable to that (64 mM for frequency and 42 mM for amplitude, respectively) of sEPSCs in culture hippocampal neurons (Gonzalez et al., 2007) and about 100 times larger than that (410 nM) in blocking DRG Na þ currents (Kim et al., 2011) . The differences may be due to the celltype-specific or subtype-specific HCN channel isoforms. In our study as presented here, maximum blocking effect of minocycline on Ih was nearly 40%, probably owing to the saturation of binding site to HCN channels. The similar blocking effect on Ih currents has been reported for nicotine on oriens-lacunosum moleculare (O-LM) interneurons (maximum 39%) (Griguoli et al., 2010) and serotonin on ventral tegmental area neurons (maximum 40%) (Liu et al., 2003) . HCN channels are expressed in spinal dorsal horn (Antal et al., 2004; Hughes et al., 2013; Papp et al., 2006; Tu et al., 2004; Weng et al., 2012) , and Ih has been recorded in subset of SG neurons (Grudt and Perl, 2002; Melnick, 2008; Tadros et al., 2012; Yasaka et al., 2010) . The blockade of Ih by CsCl and ZD7288 shown in the present study is in agreement with previous publications (Doan et al., 2004; Southan et al., 2000; Van Hook and Berson, 2010; van Welie et al., 2004) . Besides postsynaptic HCN channels, axonal and presynaptic HCN channels have also been reported to be functionally related to synaptic transmission (Aponte et al., 2006; Chevaleyre and Castillo, 2002; Lupica et al., 2001; Peng et al., 2010; Southan et al., 2000) . Minocyclineinduced inhibition of Ih was not influenced by bath application of TTX, CNQX, APV, bicuculine methiodide, and strychinine, which strongly suggests the direct action of this medicine on postsynaptic HCN channels.
Four different subunits of HCN channels have been cloned, which may assemble to form homotetramers or heterotetramers with different biophysical properties (Biel et al., 2009; He et al., 2014) . Variance of Ih amplitude reflects different expression types of HCN channels in SG neurons. Among them, HCN2 and HCN4, but not HCN1 and HCN3 subunits have been shown to confer high sensitivity to cAMP. Additional experiments are needed to determine the composition of native HCN channels in SG cells. Because cAMP activator forskolin potentiated Ih in only 19% of the neurons examined, this suggests that HCN1 or HCN3, but not HCN2 and HCN4 may be the target of minocycline. In contrast to extracellular application of minocycline, intracellular included minocycline did not alter Ih, indicating an extracellular binding site of minocycline on HCN channels.
Our findings that the inhibitory effect of minocycline on Ih is consistent with the significantly reduced V 0.5 and negatively shift of activation curve. The effect of minocycline on SG neurons closely resembles the effect of capsaicin on DRG neurons, which showed a similar negative shift in the voltage dependence of Ih activation (Kwak, 2012) . The mean activation V 0.5 of Ih was À86.9 mV in SG neurons, which is similar to that for O-LM interneurons (À85.8 mV) (Griguoli et al., 2010) , stellate cells of the mammalian ventral cochlear nucleus (À86.8 mV) (Rodrigues and Oertel, 2006) , and dorsal horn ganglion neurons (À86.3 mV) (Momin et al., 2008) . However, Vrev of Ih was not significantly altered by minocycline (À42.0 mV vs. À40.7 mV). The lack of a change in Vrev indicates the ion selectivity of HCN channels is not affected by minocycline. Vrev values in SG neurons were comparable to ganglion-cell photoreceptors (À43 mV) (Van Hook and Berson, 2010) and ventral tegmental area dopamine neurons (À39 mV) (Pape and McCormick, 1989) .
Because Ih contributes to pacemaker activity in CNS neurons, it might also modulate APs of SG neurons. After the application of minocycline, APs rates were decreased, suggesting that minocycline could reduce the intrinsic excitability of SG neurons possibly through inhibiting Ih currents. One likely explanation is that minocycline may reduce an inward current already active at rest, which exerts a tonic depolarizing action on SG cells. This is consistent with the results showing that ZD7288 decreases APs frequency in vomeronasal sensory neurons (Dibattista et al., 2008) or ganglioncell photoreceptors (Van Hook and Berson, 2010) . Specifically, minocycline slowed down the slope of the depolarization ramp leading to AP threshold in our study. Although sodium-and calcium-gated channels inhibited by minocycline in hippocampal or DRG neurons (Gonzalez et al., 2007; Kim et al., 2011) , they less likely contributed to SG neurons, because the shape of APs was not affected by minocycline, indicating a selective action of minocycline on the pacemaker current Ih. Our data is also in agreement with a previous study showing that the application of 100 mM minocycline reduces the evoked APs in cultured hippocampal neurons (Gonzalez et al., 2007) .
Conclusions
Taken together, our studies as presented here demonstrate that the actions of minocycline on HCN channels, including the reduction of Ih amplitude and negative modification of the voltage dependence of activation, are sufficient to suppress the excitability of SG neurons. As SG is an important element of integration network in pain transmission, our findings suggest this medicine as a potential treatment therapy for HCN channel activation-mediated chronic pain.
